Bring on

An Approved Immunotherapy


BAVENCIO® (avelumab) is an immunotherapy treatment

BAVENCIO is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial carcinoma (UC) when it has spread or cannot be removed by surgery (advanced UC).

  • BAVENCIO may be used as maintenance treatment when your cancer has responded or stabilized after you have received platinum-containing chemotherapy as your first treatment
  • It is not known if BAVENCIO is safe and effective in children under the age of 12

BAVENCIO is an immunotherapy—a medicine that may treat certain cancers by working with your immune system.

  • BAVENCIO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended

What is the most important information I should know about BAVENCIO?

Before taking BAVENCIO

Share information with your healthcare provider

It’s important to share information about yourself and your medical history with your healthcare provider and discuss possible limitations you may have when taking this treatment.

Before you receive BAVENCIO, tell your healthcare provider about all of your medical conditions, including if you:

  • have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
  • have received an organ transplant
  • have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
  • have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
  • have heart problems or high blood pressure
  • have diabetes
  • have a high cholesterol level in your blood
  • are pregnant or plan to become pregnant. BAVENCIO can harm your unborn baby
    • Females who are able to become pregnant:
      • You should use an effective method of birth control during your treatment and for at least 1 month after the last dose of BAVENCIO. Talk to your healthcare provider about birth control methods that you can use during this time
  • are breastfeeding or plan to breastfeed. It is not known if BAVENCIO passes into your breast milk. Do not breastfeed during treatment and for at least 1 month after the last dose of BAVENCIO

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The Role of Maintenance Treatment

BAVENCIO maintenance treatment may be an important part of your treatment plan

  • Platinum-containing chemotherapy has been the recommended treatment for advanced UC for over 20 years.
  • But there may be more that can be done if platinum-containing chemotherapy has worked for you: Maintenance treatment may help you keep fighting your advanced UC after it has responded to or stabilized with platinum-containing chemotherapy as your first treatment